Good Vaccine News Has Immediate Impact on the Stock Market

The prospect of a coronavirus vaccine is a big driver in the current bull market, says UBS. When positive news breaks about vaccine developments, the S&P 500 jumps 1.6% on average for the day, according to a bank study headed by strategist Keith Parker.

Upbeat vaccine news has added around 6.5 percentage points to the S&P 500’s return since May, UBS calculates, after doing an artificial intelligence (AI) review of market performance. May is when vaccine developments started getting news coverage. Since then, the index has risen 25%, which means that a quarter of that increase came from optimism about a vaccine.

An example of the buoyancy: On Aug, 24, the market rose 1% and hit another all-time high after the US Food and Drug Administration (FDA) announced its approval for the emergency use of convalescent plasma—the antibody-heavy blood component taken from people who have recovered from COVID-19. While the efficacy of this treatment has lately been called into question, in that one shining moment last week, investors’ pulses quickened.

A host of drug firms are toiling away on a serum to inoculate the population from COVID-19: Moderna, AstraZeneca, and Pfizer, to name a few. Johnson & Johnson has undertaken the largest clinical trial of a virus vaccine to date, signing up 60,000 people globally as test participants. Some of these companies’ shares have benefited more than others, with Moderna up 34% since May and J&J flat.

Want the latest institutional investment industry news and insights? Sign up for CIO newsletters. 

Perhaps the lack of an overall pharma stock boost stems from the fact that only one or two of those firms will likely emerge as the developer of the salvation vaccine. In the UBS study’s view, a greater than 50% probability exists for a working vaccine in 2021’s first half. Nonetheless, the study went on to say, “the equity market is pricing in less than that” for pharma stocks. “This implies the balance of risks is tilted to the upside.”

But right now, it’s the broader market that is taking heart: An effective vaccine, from whichever company, would solve a lot of problems for the economy at large, and for stricken industries such as airlines and hotels in particular.

By UBS’s measure, on days with positive vaccine news, the winners are airlines, hotels/leisure, autos, energy, durables, apparel, industrials, banks, and consumer finance. Pharma and biotech, not so much.

The UBS study also had some salutary tidings for small-cap stocks, which have trailed in the current rally. On good news days for vaccine, the smaller stocks outpaced the larger ones by 2 percentage points. For whatever reason, that halo effect didn’t extend to value stocks, which also have been laggards.

This Rally Will Last a Long Time, Invesco Predicts

Seth Klarman’s Diagnosis for the Market Rally: Virus-Prompted Impatience

Tags: AstraZeneca, Coronavirus, Johnson & Johnson, Moderna, Pfizer, S&P 500, Stocks, UBS, vaccines

The $15.65 billion Ohio Police & Fire Pension Fund’s investment committee has approved a 5% allocation to gold to help give the portfolio a strong diversifier to its growth investments, while also providing a hedge against inflation.

The move comes as gold has reached an all-time high this year and as it is up more than 20% year to date. Even Warren Buffett, known to disdain the idea of investing in the precious metal, has joined the 2020 gold rush.

The Ohio fund’s investment committee reported that Wilshire Associates, its general investment consultant, began an asset allocation review and presentation last week. And although the comprehensive review is still ongoing, the fund’s board approved one change to the portfolio so far, which was the addition of the 5% allocation to gold.

The fund’s investment staff and Wilshire are now exploring how to best implement the strategy. The fund said it won’t hire a new manager, and there is so far no timeline for implementation. To allow for the additional 5% allocation, the pension’s board also approved raising the current leverage amount on the total portfolio to 25% from 20%.

Never miss a story — sign up for CIO newsletters to stay up-to-date on the latest institutional investment industry news. 

The fund also reported a strong rebound for its investments in the second quarter, as its portfolio earned 9.21% during the period, and the asset value of the pension has risen by $750 million since May. However, due to the rough first quarter, the fund’s investments are still down 5.5% for the year so far.

The board also approved the rebalancing of its open-end real estate portfolio, specifically open-end funds, as pitched by its real estate investment consultant The Townsend Group. As part of the rebalancing process, the board approved a full redemption request from Jamestown Premier Property Fund (the pension’s current investment is valued at approximately $86.4 million), a partial redemption request of $50 million from Heitman Core Property Fund, and a partial redemption request of $50 million from JP Morgan Strategic Property Fund.

The pension fund’s asset allocation as of the end of July was 18.7% in US equity, 17.6% in non-US equity, 12.9% in fixed income, 10.6% in real estate, 9.4% in high-yield bonds, 9.3% in US inflation-protected securities, 8.6% in private markets, 5.4% in master limited partnerships, 3.5% in real assets, 2.8% in private credit, and 1.3% in cash.